The first results of a COVID-19 vaccination study found the treatments are safe and effective for children between 5 and 11, Pfizer and BioNTech announced Monday after a study of more than 2,200 children.
Read the full article:
Georgia Recorder
The first results of a COVID-19 vaccination study found the treatments are safe and effective for children between 5 and 11, Pfizer and BioNTech announced Monday after a study of more than 2,200 children.
Read the full article:
Georgia Recorder